“We're going to Assess how the commercialization of the substance suits in with our enterprise model at Adastra in an effort to place ourselves to guidance the demand from customers for a safe supply of copyright,” explained chief executive officer Michael Forbes inside a news launch. The business instructed VICE News it would not be commenting